Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291002279> ?p ?o ?g. }
- W4291002279 endingPage "64" @default.
- W4291002279 startingPage "58" @default.
- W4291002279 abstract "To assess the current management of menopause in France with regard to menopause-related and genitourinary symptoms, with a focus on use of menopause hormone therapy (MHT).The ELISA Study is a population-based survey of 5004 French representative women aged 50 to 65 years. From July to August 2020, the participating women answered an online computer-assisted web interview on menopause-related and genitourinary symptoms and their management, including use of MHT.Prevalence of menopause-related and genitourinary symptoms in postmenopausal women. Management of these symptoms, including the reasons for not doing so, management by health care providers, and use of MHT.Among the 5004 selected women, 4041 whose postmenopausal status was confirmed were included in the final analyses. Of the untreated 3685 women, 87 % reported at least 1 menopausal symptom, with a significantly higher percentage of symptomatic women in the 50-54 age group (92 %, p < 0.05) than in the other two age groups (55-59 years: 89 % and 60-64 years: 82 %). 68 % of the surveyed women experienced on average 2.5 symptoms of the genitourinary syndrome of menopause (GSM). Using a visual analogue scale (VAS) from 0 (no impact) to 10 (high impact) to evaluate the impact of menopausal/GSM symptoms on their quality of life, mean VAS score was 5.9 (SD: 2.2), with 25 % of the women aged 55-59 years rating their quality of life between 8 and 10. 61 % of the surveyed women reported being regularly followed by a health care professional. 44 % of women reported never having discussed their menopausal/GSM symptoms with a health care provider. The main reasons were because menopause is a normal part of women's lives, because it was not necessary to do so, or their symptoms were not serious enough. Only 242 women (6 %) were current MHT users, of whom 49 % were using estrogen-alone therapy and 71 % were using transdermal estrogens. Fear of hormones (35 %) and MHT side-effects (25 %) were the main reasons given for not using MHT. 62 % of the women reported that the decision not to take MHT was supported by their physician.This large population-based survey confirmed not only the high prevalence of menopause-related and GSM symptoms in postmenopausal women within the first 10-15 years after menopause, but also the very low percentage of MHT users in France. Twenty years after the publication of the initial Women's Health Initiative (WHI) results, management of postmenopausal women is still characterized by unmet needs in menopausal care. Therefore, there is a strong need to educate the public and health care providers about menopause-related problems and possible solutions, including MHT, through dedicated educational programs." @default.
- W4291002279 created "2022-08-13" @default.
- W4291002279 creator A5001649940 @default.
- W4291002279 creator A5036560569 @default.
- W4291002279 creator A5037493985 @default.
- W4291002279 creator A5059487591 @default.
- W4291002279 creator A5080174215 @default.
- W4291002279 creator A5089367968 @default.
- W4291002279 creator A5090831210 @default.
- W4291002279 date "2022-12-01" @default.
- W4291002279 modified "2023-10-16" @default.
- W4291002279 title "Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management" @default.
- W4291002279 cites W1586699954 @default.
- W4291002279 cites W1593442063 @default.
- W4291002279 cites W1968760782 @default.
- W4291002279 cites W1970207413 @default.
- W4291002279 cites W1971955778 @default.
- W4291002279 cites W1991088575 @default.
- W4291002279 cites W2022105365 @default.
- W4291002279 cites W2022361277 @default.
- W4291002279 cites W2047321638 @default.
- W4291002279 cites W2059030353 @default.
- W4291002279 cites W2062168247 @default.
- W4291002279 cites W2071095243 @default.
- W4291002279 cites W2104017695 @default.
- W4291002279 cites W2117920697 @default.
- W4291002279 cites W2126228459 @default.
- W4291002279 cites W2143515930 @default.
- W4291002279 cites W2155601666 @default.
- W4291002279 cites W2272134694 @default.
- W4291002279 cites W2313964113 @default.
- W4291002279 cites W2333138815 @default.
- W4291002279 cites W2407932094 @default.
- W4291002279 cites W2442041940 @default.
- W4291002279 cites W2754589635 @default.
- W4291002279 cites W2809039822 @default.
- W4291002279 cites W2905682711 @default.
- W4291002279 cites W3014012646 @default.
- W4291002279 cites W3092559956 @default.
- W4291002279 cites W3114406896 @default.
- W4291002279 cites W3123956217 @default.
- W4291002279 cites W3138215196 @default.
- W4291002279 cites W3165078348 @default.
- W4291002279 cites W3173732646 @default.
- W4291002279 cites W3174595442 @default.
- W4291002279 cites W3202940791 @default.
- W4291002279 cites W4221049122 @default.
- W4291002279 cites W4281607077 @default.
- W4291002279 cites W4283835704 @default.
- W4291002279 doi "https://doi.org/10.1016/j.maturitas.2022.08.003" @default.
- W4291002279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36058119" @default.
- W4291002279 hasPublicationYear "2022" @default.
- W4291002279 type Work @default.
- W4291002279 citedByCount "2" @default.
- W4291002279 countsByYear W42910022792023 @default.
- W4291002279 crossrefType "journal-article" @default.
- W4291002279 hasAuthorship W4291002279A5001649940 @default.
- W4291002279 hasAuthorship W4291002279A5036560569 @default.
- W4291002279 hasAuthorship W4291002279A5037493985 @default.
- W4291002279 hasAuthorship W4291002279A5059487591 @default.
- W4291002279 hasAuthorship W4291002279A5080174215 @default.
- W4291002279 hasAuthorship W4291002279A5089367968 @default.
- W4291002279 hasAuthorship W4291002279A5090831210 @default.
- W4291002279 hasConcept C126322002 @default.
- W4291002279 hasConcept C131872663 @default.
- W4291002279 hasConcept C133507102 @default.
- W4291002279 hasConcept C159110408 @default.
- W4291002279 hasConcept C187212893 @default.
- W4291002279 hasConcept C2778562196 @default.
- W4291002279 hasConcept C2779951463 @default.
- W4291002279 hasConcept C2908647359 @default.
- W4291002279 hasConcept C29456083 @default.
- W4291002279 hasConcept C71924100 @default.
- W4291002279 hasConcept C74909509 @default.
- W4291002279 hasConcept C99454951 @default.
- W4291002279 hasConceptScore W4291002279C126322002 @default.
- W4291002279 hasConceptScore W4291002279C131872663 @default.
- W4291002279 hasConceptScore W4291002279C133507102 @default.
- W4291002279 hasConceptScore W4291002279C159110408 @default.
- W4291002279 hasConceptScore W4291002279C187212893 @default.
- W4291002279 hasConceptScore W4291002279C2778562196 @default.
- W4291002279 hasConceptScore W4291002279C2779951463 @default.
- W4291002279 hasConceptScore W4291002279C2908647359 @default.
- W4291002279 hasConceptScore W4291002279C29456083 @default.
- W4291002279 hasConceptScore W4291002279C71924100 @default.
- W4291002279 hasConceptScore W4291002279C74909509 @default.
- W4291002279 hasConceptScore W4291002279C99454951 @default.
- W4291002279 hasLocation W42910022791 @default.
- W4291002279 hasLocation W42910022792 @default.
- W4291002279 hasOpenAccess W4291002279 @default.
- W4291002279 hasPrimaryLocation W42910022791 @default.
- W4291002279 hasRelatedWork W1975489058 @default.
- W4291002279 hasRelatedWork W2430407840 @default.
- W4291002279 hasRelatedWork W2474491470 @default.
- W4291002279 hasRelatedWork W2639558324 @default.
- W4291002279 hasRelatedWork W2898357149 @default.
- W4291002279 hasRelatedWork W2906967327 @default.
- W4291002279 hasRelatedWork W2981820606 @default.